120 related articles for article (PubMed ID: 9501848)
1. Plasmodium falciparum: effect of chemical structure on efficacy and specificity of antisense oligonucleotides against malaria in vitro.
Barker RH; Metelev V; Coakley A; Zamecnik P
Exp Parasitol; 1998 Jan; 88(1):51-9. PubMed ID: 9501848
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Plasmodium falciparum malaria using antisense oligodeoxynucleotides.
Barker RH; Metelev V; Rapaport E; Zamecnik P
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):514-8. PubMed ID: 8552672
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles.
Föger F; Noonpakdee W; Loretz B; Joojuntr S; Salvenmoser W; Thaler M; Bernkop-Schnürch A
Int J Pharm; 2006 Aug; 319(1-2):139-46. PubMed ID: 16713146
[TBL] [Abstract][Full Text] [Related]
4. Anti-sense oligodeoxynucleoside phosphorothioates nonspecifically inhibit invasion of red blood cells by malaria parasites.
Ramasamy R; Kanagaratnam R; Misiura K; Rebowski G; Amerakoon R; Stec WJ
Biochem Biophys Res Commun; 1996 Jan; 218(3):930-3. PubMed ID: 8579616
[TBL] [Abstract][Full Text] [Related]
5. [Plasmodium falciparum: antimalarial activities of antisense oligodeoxyribonucleotides targeted to histidine-rich protein genes in vitro].
Yu XB; Fang JM; Luo SH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(4):200-3. PubMed ID: 12567657
[TBL] [Abstract][Full Text] [Related]
6. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
[TBL] [Abstract][Full Text] [Related]
7. Structural and immunostimulatory properties of Y-shaped DNA consisting of phosphodiester and phosphorothioate oligodeoxynucleotides.
Matsuoka N; Nishikawa M; Mohri K; Rattanakiat S; Takakura Y
J Control Release; 2010 Dec; 148(3):311-6. PubMed ID: 20887761
[TBL] [Abstract][Full Text] [Related]
8. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides.
Reed JC; Stein C; Subasinghe C; Haldar S; Croce CM; Yum S; Cohen J
Cancer Res; 1990 Oct; 50(20):6565-70. PubMed ID: 2208117
[TBL] [Abstract][Full Text] [Related]
9. A novel Plasmodium falciparum expression system for assessing antifolate resistance caused by mutant P. vivax dihydrofolate reductase-thymidylate synthase.
O'Neil MT; Korsinczky ML; Gresty KJ; Auliff A; Cheng Q
J Infect Dis; 2007 Aug; 196(3):467-74. PubMed ID: 17597462
[TBL] [Abstract][Full Text] [Related]
10. Hybridization arrest of cell-free translation of the malarial dihydrofolate reductase/thymidylate synthase mRNA by anti-sense oligodeoxyribonucleotides.
Sartorius C; Franklin RM
Nucleic Acids Res; 1991 Apr; 19(7):1613-8. PubMed ID: 2027768
[TBL] [Abstract][Full Text] [Related]
11. Antisense inhibitory effect: a comparison between 3'-partial and full phosphorothioate antisense oligonucleotides.
Galderisi U; Di Bernardo G; Melone MA; Galano G; Cascino A; Giordano A; Cipollaro M
J Cell Biochem; 1999 Jul; 74(1):31-7. PubMed ID: 10381259
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the effect of retinol on Plasmodium falciparum in vitro.
Hamzah J; Davis TM; Skinner-Adams TS; Beilby J
Exp Parasitol; 2004; 107(3-4):136-44. PubMed ID: 15363939
[TBL] [Abstract][Full Text] [Related]
13. Characterization of antisense oligonucleotides comprising 2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (FANA): specificity, potency, and duration of activity.
Ferrari N; Bergeron D; Tedeschi AL; Mangos MM; Paquet L; Renzi PM; Damha MJ
Ann N Y Acad Sci; 2006 Oct; 1082():91-102. PubMed ID: 17145930
[TBL] [Abstract][Full Text] [Related]
14. Phosphorothioate-phosphodiester oligonucleotide co-polymers: assessment for antisense application.
Ghosh MK; Ghosh K; Cohen JS
Anticancer Drug Des; 1993 Feb; 8(1):15-32. PubMed ID: 8386513
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligonucleotides targeting malarial aldolase inhibit the asexual erythrocytic stages of Plasmodium falciparum.
Wanidworanun C; Nagel RL; Shear HL
Mol Biochem Parasitol; 1999 Jul; 102(1):91-101. PubMed ID: 10477179
[TBL] [Abstract][Full Text] [Related]
16. Efficient delivery of intact phosphodiester oligonucleotides by poly-beta-amino esters.
Remaut K; Symens N; Lucas B; Demeester J; De Smedt SC
J Control Release; 2010 May; 144(1):65-74. PubMed ID: 20114066
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition of hepatitis C virus by antisense oligodeoxynucleotide in vitro].
Liu Y; Chen Z; He N
Zhonghua Yi Xue Za Zhi; 1997 Aug; 77(8):567-70. PubMed ID: 9772458
[TBL] [Abstract][Full Text] [Related]
18. Anti-Plasmodium activity of ceramide analogs.
Labaied M; Dagan A; Dellinger M; Gèze M; Egée S; Thomas SL; Wang C; Gatt S; Grellier P
Malar J; 2004 Dec; 3():49. PubMed ID: 15588325
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium falciparum: gene mutations and amplification of dihydrofolate reductase genes in parasites grown in vitro in presence of pyrimethamine.
Thaithong S; Ranford-Cartwright LC; Siripoon N; Harnyuttanakorn P; Kanchanakhan NS; Seugorn A; Rungsihirunrat K; Cravo PV; Beale GH
Exp Parasitol; 2001 Jun; 98(2):59-70. PubMed ID: 11465989
[TBL] [Abstract][Full Text] [Related]
20. Absolute bioavailability of 2'-O-(2-methoxyethyl)-modified antisense oligonucleotides following intraduodenal instillation in rats.
Geary RS; Khatsenko O; Bunker K; Crooke R; Moore M; Burckin T; Truong L; Sasmor H; Levin AA
J Pharmacol Exp Ther; 2001 Mar; 296(3):898-904. PubMed ID: 11181922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
